ArchPoint Investors - Q4 2016 holdings

$170 Million is the total value of ArchPoint Investors's 95 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .

 Value Shares↓ Weighting
XBI NewSPDR S&P Biotech ETF$2,249,00038,000
+100.0%
1.32%
BSX NewBoston Scientific Corp$2,098,00097,000
+100.0%
1.23%
BIIB NewBiogen Idec Inc$1,900,0006,700
+100.0%
1.12%
XLV NewHealth Care Select Sector SPDR$1,039,00015,070
+100.0%
0.61%
MAT NewMattel Inc$468,00016,980
+100.0%
0.28%
MDC NewM.D.C. Holdings, Inc.$281,00010,937
+100.0%
0.16%
DXJ NewWisdomTree Japan Hedged Equity$221,0004,470
+100.0%
0.13%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Hamlin Capital Management LLC #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LA Z BOY INC42Q3 202324.1%
Thermo Fisher SCNTFC42Q3 20234.3%
Genuine Parts Co Com42Q3 20234.4%
Dorchester Minerals Lp Com Uni42Q3 20237.7%
CURTISS WRIGHT CORP42Q3 20233.2%
Activision Blizzard Inc Put Op42Q3 20233.4%
APPLE INC.42Q3 20233.8%
Cisco Systems Inc42Q3 20232.7%
Exxon Mobil Corporation42Q3 20230.5%
Enterprise Products Partners L41Q3 20231.9%

View ArchPoint Investors's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View ArchPoint Investors's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (169998000.0 != 169997000.0)

Export ArchPoint Investors's holdings